Risk of breast cancer relapse lasts for years, says study
According to researchers, extending hormone-based therapy beyond five years continues to suppress and reduce recurrence and mortality.
Nov 20, 2017, 19:33 PM IST
According to researchers, extending hormone-based therapy beyond five years continues to suppress and reduce recurrence and mortality.
Nov 20, 2017, 19:33 PM IST